Clinical Trial Update: Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections [Phase 1]

View source ↗

Summary

Phase 1 trial updating safety and tolerability of ceftazidime-avibactam in pediatric patients with suspected or confirmed systemic infections; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Infections

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Systemic Infections | Phase 1 | Status: COMPLETED | Results posted: 2015-05-27